Genetic heart conditions could be cured for first time in ‘defining moment’ theguardian.com/society/2022/j…

A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project rdcu.be/cSG0R

Put the "S" in ESG by taking care of your most important community: our kids. The Bardo Open 2022 is on August 15th. (see link in bio) All proceeds of this event will fund a promising Osteosarcoma research at Medical University of SC MUSC College of Medicine in partnership with Myrovlytis Trust

We were delighted to attend the MIB Agents Osteosarcoma Alliance FACTOR conference. The osteosarcoma community joined forces for an inspirational cause – to make things better for those with osteosarcoma. Read the highlights here 👉 bit.ly/3zO1khF The Osteosarcoma Institute Alejandro Sweet-Cordero, MD

We interviewed Dr Sandra Strauss UCLH about the ICONIC trial funded by Bone Cancer Research Trust. The trial is actively recruiting in the UK and aims to increase our understanding of #Osteosarcoma and help direct future research. Watch the full interview here 👉bit.ly/3w3Z9Ec

Happy to chat informally...

It's worth spending some time discussing what this new @whitehouse Open Science policy does and doesn't do, and what is still be to determined. whitehouse.gov/ostp/news-upda…

Are you a cancer researcher interested in writing a review on some aspect of molecular biosciences, including cell signaling and biochemistry? I'm a reviews commissioning editor for FEBS Letters and would be interested to hear your ideas. Please RT.

New malaria vaccine is world-changing, say scientists bbc.in/3cYMFHF

We now have over 150 people signed up to the #BHDsyndrome International Registry. Can you help us get to 200 people? Find out more about the #registry and sign up at birt.healthie.net #kidneycancer #pneumothorax #raredisease

Attend Beacon for Rare Diseases’s #DrugRepo22 to gain the tools, connections and ways needed to bring your repurposing project to the forefront. Their conference will help you deliver your repurposing project, so others can look to you as a beacon of hope. lght.ly/6oben8g

We are looking for help refining our innovative #osteosarcoma clinical trial database, ONTEX. If you have a connection to osteosarcoma (as a patient, family member or doctor) we would really appreciate your input. The survey takes no more than 5 minutes to complete. Please RT!

Pls RT & help increase the number & diversity of excellent mathematicians. I’m hosting FREE online maths circles EVERY week. 13 circles per week. 6 ability levels Fully interactive. Anyone, anywhere welcome. Let's build the world's biggest maths circles. parallel.org.uk

Tomorrow we are sending out the first Osteosarcoma Now Newsletter! Sign up for research updates and opportunities to get involved with our work. We will also be sharing the work of other charities including the MIB Agents Osteosarcoma Alliance webinar series. 👉Sign up now: bit.ly/3r639kP

Today is #RareCancerDay! #Osteosarcoma is a rare cancer. Join the herd and help National Organization for Rare Disorders (NORD) raise awareness and spread the word for #RareCancer. Visit bit.ly/RCD-22 to learn more.

Genomics behemoth Illumina just unveiled what it calls its fastest, most cost-efficient sequencing machines yet, one that slashes the cost to just $200 per human genome. (Via WIRED) trib.al/2L5uBsE

2 days ago I randomly bumped into the doctor who in 2017 told me “the good news is the problem you have in your hip can be fixed but you won’t be able to play professional sport again.” I think we dispelled that myth the last 5 days.😉Goodnight ❤️

"I do not need to display luxury cars, luxury homes, trips, even planes. I prefer that my people receive a little of what life has given me," said the 30-year-old Senegalese Bayern Munich player.

👏 More than 200 children cured of hepatitis C in world-first NHS scheme theguardian.com/society/2023/m…

To Anna’s friends and former colleagues who follow her account. I’m sorry if I haven’t been able to contact you more directly and you are only finding out from this.